Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Franklin Templeton

Putnam Sustainable Future Fund Class A Shares (PMVAX)

Ticker PMVAX · · Holdings as of Jul 31, 2026

Expense ratio
1.02%$102/yr per $10k
5-yr return
+8.3%annualized
1-yr return
+8.4%as of Dec 2024
Net assets
$321.0Mall share classes
Holdings
122

Bottom line

Is PMVAX a good fund? The bottom line

PMVAX is the Class A share class of Putnam Sustainable Future Fund, a managed large blend mutual fund from Franklin Templeton.

Its expense ratio is 1.02% — about $102 a year on every $10,000 invested, more expensive than 65% of large blend funds we track.

It returned +8.4% over one year, +8.3% a year over five years, +8.0% a year over ten (as of Dec 31, 2024, per its prospectus).

With $321 million in net assets and 122 holdings, its largest position is U.S. Treasury Bills (5.7%) and the top 10 make up 22.2% of the portfolio.

This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.

What to watch

  • Front-end sales load up to 5.75%
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What PMVAX invests in

The fund seeks capital appreciation.

The fund invests mainly in common stocks of U.S. companies of any size, with a focus on companies whose products and services we believe provide solutions that directly contribute to sustainable social, environmental and economic development (Solutions Companies). Stocks of this type of company are typically, but not always, considered to be growth stocks. Growth stocks are stocks of companies whose revenues, earnings, or cash flows are expected to grow faster than those of similar firms, and whose business growth and other characteristics may lead to an increase in stock price. The Investment Manager, as defined below, may consider, among other factors, a companys impact on sustainable environmental, social and economic development (as described below), valuation, financial strength, growth potential, competitive position in its industry, projected future earnings, cash flows and…

From the fund's prospectus (filed Aug 25, 2025).

PMVAX performance

Fund calendar-year total returns, 2015–2024 2015: −4.3%; 2016: +13.0%; 2017: +10.6%; 2018: −6.9%; 2019: +29.8%; 2020: +52.7%; 2021: +5.8%; 2022: −33.9%; 2023: +28.6%; 2024: +15.0% −4% 2015 +13% 2016 +11% 2017 −7% 2018 +30% 2019 +53% 2020 +6% 2021 −34% 2022 +29% 2023 +15% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
PMVAX+8.4%+8.3%+8.0%
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2024

Full PMVAX performance history →

What PMVAX costs

On a $10,000 investment, PMVAX's 1.02% expense ratio costs about $102 a year. The prospectus estimates $1,751 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full PMVAX fee table →

PMVAX top 10 holdings

#Holding% of fund
1U.S. Treasury Bills5.69%
2HSBC Securities (USA) Inc.3.63%
3Citigroup Global Markets, Inc.2.15%
4Broadcom, Inc.1.99%
5BNP Paribas SA1.89%
6BofA Securities1.86%
7Marvell Technology, Inc.1.39%
8Mastercard, Inc.1.37%
9Putnam Short Term Investment Fund1.15%
10GE Vernova, Inc.1.12%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 22.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to PMVAX

More funds like PMVAX →

PMVAX FAQ

What is the expense ratio of PMVAX?
PMVAX's expense ratio is 1.02%, which works out to about $102 a year for every $10,000 invested. The prospectus estimates total costs of $1,751 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is PMVAX a good investment?
It depends on your goals, but the data points to: front-end sales load up to 5.75%; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does PMVAX hold?
PMVAX's largest holdings are U.S. Treasury Bills (5.7%), HSBC Securities (USA) Inc. (3.6%), Citigroup Global Markets, Inc. (2.2%), Broadcom, Inc. (2.0%), BNP Paribas SA (1.9%). It holds 122 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is PMVAX's 5-year return?
PMVAX returned +8.3% a year over the five years ending Dec 31, 2024, and +8.0% a year over ten years. Past performance does not guarantee future results.
Does PMVAX have a sales load?
Yes. PMVAX has a maximum front-end sales charge of 5.75%. It may charge a deferred sales charge of up to 1% if sold early.
Who manages PMVAX?
PMVAX is offered by Franklin Templeton through Putnam Investment Funds.